Evaxion A (EVAX) Shares Outstanding (Weighted Average) (2019 - 2026)

Evaxion A (EVAX) reported Shares Outstanding (Weighted Average) of $417.0 billion for Q1 2026, up 50.92% on a YoY basis from $276.3 billion in Q1 2025, and up 2540.81% quarter-over-quarter from $15.8 billion in Q4 2025.

Evaxion A (EVAX) Shares Outstanding (Weighted Average) (2019 - 2026) Analysis & Trends

Evaxion A has reported Shares Outstanding (Weighted Average) for 8 years, with the latest figure at $417.0 billion in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 50.92% year-over-year to $417.0 billion; the trailing twelve-month figure through Mar 2026 stood at $417.0 billion (up 50.92% YoY), and the FY2025 full-year result was $417.0 million, up 3865.49% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $417.0 billion, up from $15.8 billion in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $417.0 billion in Q1 2026, with the low at $10.0 in Q3 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $46.6 billion across 5 years, with a median of $3.8 billion in 2022.
  • The largest YoY upside for Shares Outstanding (Weighted Average) was 921039756566.67% in 2025 against a maximum downside of 100.0% in 2025.
  • Evaxion A's Shares Outstanding (Weighted Average) stood at $23.6 million in 2022, then jumped by 60.32% to $37.9 million in 2023, then plunged by 72.25% to $10.5 million in 2024, then soared by 150061.66% to $15.8 billion in 2025, then surged by 2540.81% to $417.0 billion in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $417.0 billion (Q1 2026), $15.8 billion (Q4 2025), and $10.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 104.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 417.01 Bn
Dec 31, 2025 15.79 Bn
Sep 30, 2025 10.00
Jun 30, 2025 11.82 Bn
Mar 31, 2025 276.31 Bn
Dec 31, 2024 10.52 Mn
Sep 30, 2024 55.26 Bn
Jun 30, 2024 120.00
Mar 31, 2024 30.00
Dec 31, 2023 37.90 Mn
Sep 30, 2023 4.42 Bn
Jun 30, 2023 460.00
Mar 31, 2023 4.22 Bn
Dec 31, 2022 23.64 Mn
Sep 30, 2022 3.86 Bn
Jun 30, 2022 450.00
Mar 31, 2022 3.76 Bn
Dec 31, 2021 23.20 Mn
Sep 30, 2021 3.13 Bn
Jun 30, 2021 3.13 Bn